Showing results (41-50 of 260) with videos related to
Sort By:
Pageof 26
Clinical Pharmacology and Therapeutics|October 1, 1996
Differences between white subjects and Chinese subjects in the in vivo inhibition of cytochrome P450s 2C19, 2D6, and 3A by omeprazoleY Caraco, G R Wilkinson, A J WoodDrug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1993
Hepatic elimination in the rat of ditekiren (U-71038), a renin inhibitor pseudohexapeptideA Adedoyin, P R Perry, G R WilkinsonThe American Journal of Gastroenterology|February 24, 2000
Trazodone-induced hepatotoxicity: a case report with comments on drug-induced hepatotoxicityN F Fernandes, R R Martin, S SchenkerDrug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1977
Disposition of carbamazepine and its 10,11-epoxide metabolite in the isolated perfused rat liverA Rane, D G Shand, G R WilkinsonThe Journal of Pharmacology and Experimental Therapeutics|February 1, 1977
Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearanceA Rane, G R Wilkinson, D G ShandThe New England Journal of Medicine|March 19, 1981
Reduction of liver blood flow and propranolol metabolism by cimetidineJ Feely, G R Wilkinson, A J WoodClinical Pharmacology and Therapeutics|July 1, 1990
Differences in plasma binding of drugs between Caucasians and Chinese subjectsH H Zhou, A Adedoyin, G R WilkinsonClinical Nutrition (Edinburgh, Scotland)|May 1, 2001
The effects of food restriction in man on hepatic metabolism of acetaminophenS Schenker, K V Speeg, A Perez, et al.Biochemical Pharmacology|November 15, 1989
A model of cytochrome P-450-centered hepatic dysfunction in drug metabolism induced by cobalt-protoporphyrin administrationB B Muhoberac, T Hanew, S Halter, et al.Pageof 26